Deoxygalactonojirimycin Hydrochloride
- CAS No.
- 75172-81-5
- Chemical Name:
- Deoxygalactonojirimycin Hydrochloride
- Synonyms
- Migalastat hydrochloride;Migalastat HCl;DGJ;Amigal;GR181413A;GR 181413A;GR-181413A;5-Dideoxy-1;Unii-cly7m0xd20;GALACTOSTATIN HCL
- CBNumber:
- CB5252941
- Molecular Formula:
- C6H13NO4.ClH
- Molecular Weight:
- 199.63
- MDL Number:
- MFCD00269962
- MOL File:
- 75172-81-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Melting point | 260 |
|---|---|
| storage temp. | 2-8°C |
| solubility | Methanol (Slightly), Water (Slightly) |
| form | White crystalline solid |
| color | White to Brown |
| biological source | synthetic (organic) |
| Water Solubility | water: soluble 1mg/mL |
| InChI | 1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1 |
| InChIKey | ZJIHMALTJRDNQI-OLALXQGDSA-N |
| SMILES | Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O |
| FDA UNII | CLY7M0XD20 |
| UNSPSC Code | 12352200 |
| NACRES | NA.32 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 | |||||||||
| PPE | dust mask type N95 (US), Eyeshields, Gloves | |||||||||
| Hazard Codes | Xi | |||||||||
| Risk Statements | 36/37/38 | |||||||||
| Safety Statements | 26-36 | |||||||||
| WGK Germany | 3 | |||||||||
| Hazard Note | Irritant | |||||||||
| HS Code | 29333990 | |||||||||
| Storage Class | 11 - Combustible Solids | |||||||||
| NFPA 704 |
|
Deoxygalactonojirimycin Hydrochloride price More Price(52)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | D9641 | Deoxygalactonojirimycin hydrochloride | 75172-81-5 | 2mg | $179 | 2026-04-30 | Buy |
| Sigma-Aldrich | 259544 | Deoxygalactonojirimycin, Hydrochloride Potent and selective α-galactosidase inhibitor. | 75172-81-5 | 5mg | $259 | 2022-05-15 | Buy |
| Cayman Chemical | 17179 | 1-Deoxygalactonojirimycin (hydrochloride) ≥98% | 75172-81-5 | 1mg | $42 | 2026-04-30 | Buy |
| Cayman Chemical | 17179 | 1-Deoxygalactonojirimycin (hydrochloride) ≥98% | 75172-81-5 | 5mg | $84 | 2026-04-30 | Buy |
| Cayman Chemical | 17179 | 1-Deoxygalactonojirimycin (hydrochloride) ≥98% | 75172-81-5 | 10mg | $126 | 2026-04-30 | Buy |
Deoxygalactonojirimycin Hydrochloride Chemical Properties, Uses, Production
Description
Migalastat, which is marketed by Amicus Therapeutics, received approval in the EU for the treatment of Fabry disease in adults and adolescents aged 16 or older. Fabry disease is caused by mutations of the enzyme α-galactosidase A (α-GAL A) that cause protein misfolding and prevents efficient metabolism of the glycosphingolipid globotriaosylceramide (GL3). Accumulation of GL3 in lysosomes, blood vessels, and various tissues ultimately leads to significant heart, kidney, and dermatological problems. Migalastat functions as a molecular chaperone to α- GAL A, engaging the enzyme and enabling it to adopt the proper conformation allowing for efficient breakdown of GL3. Because the standard of care prior to 2016 for treating Fabry disease was enzyme replacement therapy (ERT), migalastat’s approval in the EU represents an important advance for patients suffering from this disorder.
Chemical Properties
White Crystalline Solid
Uses
Proven to be an extremely potent and selective a-D-galactosidase inhibitor.
Uses
inhibitor of b-glucosidase
Uses
Deoxygalactonojirimycin hydrochloride has been used as an α-galactosidase A inhibitor to assess the enzymatic activity of α-galactosidase A. It has also been used as an α-galactosidase A inhibitor to study its effects on the mRNA levels in human embryonic kidney (HEK) cells and hippocampal neurons.
brand name
Treatment of Fabry disease.
Biochem/physiol Actions
Deoxygalactonojirimycin hydrochloride is an inhibitor of α-galactosidase A. Deoxygalactonojirimycin exhibits therapeutic effects against Fabry disease.
Synthesis
Several unique synthetic approaches to migalastat, which is
also known as D-1-deoxygalactonojirimycin (DGJ), have been
reported in the literature. Although the most likely
commercial-scale preparation of this drug proceeds through a
microbial fermentation process disclosed in a 2015 patent, a
kilogram-scale synthesis of the drug outlined has
been described in a 2008 patent application filed by Amicus.
This route closely resembles a procedure disclosed in 1999 by
Uriel and Santoyo-Gonzalez that presented handling and
safety concerns. Commercial D-galactose (143) was treated
with five equivalents of pivaloyl imidazole (144), followed by
triflation, treatment with Hunigˉs base, and exposure to sodium
nitrite to furnish the tetrapivaloyl altofuranose triflate 145 after
recrystallization from heptane. Next, stereospecific azide
displacement of the triflate successfully delivered azidofuranose 146 in 65-70% yield. This reaction generated over 3 kg of the
desired alkyl azide after recrystallization from ethanol and
water. Lastly, palladium-catalyzed hydrogenolysis in the
presence of sodium methoxide, a methanolic acidification
step, and then a subsequent acidification step using HCl in
THF furnished migalastat hydrochloride (XV) in 70-75% yield
over the three-step sequence from 146.
target
α-galactosidase
IC 50
40 nm
References
[1] asano n, ishii s, kizu h, et al. in vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase a activity in fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives[j]. febs journal, 2000, 267(13): 4179-4186.
[2] ishii s, chang h, yoshioka h, et al. preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for fabry disease[j]. journal of pharmacology and experimental therapeutics, 2009, 328(3): 723-731.
Deoxygalactonojirimycin Hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
Deoxygalactonojirimycin Hydrochloride Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou FuRun Pharmaceutical Technology Co., Ltd | 15658004993 | 1900830611@qq.com | China | 980 | 58 |
| NewCan Biotech Limited | +86-0571-86912261 +86-15658003402 | sales@newcanbio.com | China | 1984 | 58 |
| Zhengzhou Nucleosides Biotech Co., Ltd. | 15981919713 15981919713 | sales@nucleosides.com | China | 471 | 58 |
| J & K SCIENTIFIC LTD. | 18210857532 18210857532 | jkinfo@jkchemical.com | China | 96815 | 76 |
| Chemvon Biotechnology Co., Ltd | 021-50790412 | info@chemvon.com | China | 371 | 57 |
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| Chemsky（shanghai）International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32273 | 50 |
| T&W GROUP | 021-61551611 13296011611 | contact@trustwe.com | China | 9884 | 58 |
| MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4853 | 58 |
| Guangzhou Isun Pharmaceutical Co., Ltd | 020-39119399 18927568969 | isunpharm@qq.com | China | 4773 | 55 |
View Latest Price from Deoxygalactonojirimycin Hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-09-20 | Migalastat HCl
75172-81-5
|
10G | 98%min | 30kg/month | WUHAN FORTUNA CHEMICAL CO., LTD | ||
 |
2026-09-10 | Migalastat hydrochloride
75172-81-5
|
$31.00 | 100.00% | 10g | TargetMol Chemicals Inc. | ||
 |
2026-07-15 | Migalastat hydrochloride
75172-81-5
|
$31.00 | 100.00% | 10g | TargetMol Chemicals Inc. |
-
- Migalastat HCl
75172-81-5
- $0.00
- 98%min
- WUHAN FORTUNA CHEMICAL CO., LTD
-
- Migalastat hydrochloride
75172-81-5
- $31.00
- 100.00%
- TargetMol Chemicals Inc.
-
- Migalastat hydrochloride
75172-81-5
- $31.00
- 100.00%
- TargetMol Chemicals Inc.
